Transcripts BlossomHill Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 00:00:00 30/09/2026 +04			5-day change	1st Jan Change
21.37 ^USD	+0.14%		-15.37%	-

09-29	Blossomhill Therapeutics, Inc. Presents Preclinical Data on Novel Pan-KRAS Inhibitor, Bh-501284, At the AACR Conference on Pancreatic Cancer	CI
09-21	BlossomHill Therapeutics, Inc.(NasdaqGS:BLSM) added to S&P TMI Index	CI

No results match your criteria